TGFB1 and cancer: Since the acquisition of an EMT phenotype has emerged as an important mediator of cancer progression, cancer metastases and resistance to both chemotherapy and targeted drugs such as EGFR inhibitors, thus further mechanistic studies to ascertain the role of TGF-β1- induced EMT are warranted.